TrialThe lancet. HIV2018

Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial.

ADVICE study groupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.